Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insufficient Physical Activity”

93 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 93 results

Not applicableNot Yet RecruitingNCT06784544
What this trial is testing

The Effects of Repeated Operational Stress and Limited Recovery on Resilience Capacity

Who this might be right for
Sleep, InadequateEnergy DeficitIron Absorption+1 more
United States Army Research Institute of Environmental Medicine 24
Large-scale testing (Phase 3)Study completedNCT00095147
What this trial is testing

Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 431
Large-scale testing (Phase 3)Active Not RecruitingNCT06672172
What this trial is testing

HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 284
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Not applicableLooking for participantsNCT07223112
What this trial is testing

Effectiveness of Interventions to Promote Physical Activity During Pregnancy

Who this might be right for
PregnancySedentary BehaviorInsufficient Physical Activity
University of Central Florida 60
Large-scale testing (Phase 3)Ended earlyNCT03760965
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 276
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Early research (Phase 1)Study completedNCT00541229
What this trial is testing

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

Who this might be right for
Type 2 Diabetes
Merck Sharp & Dohme LLC 103
Not applicableLooking for participantsNCT06528639
What this trial is testing

A Clinical Study on Exercise Guided by CPET to Reduce the Risk of Metabolic Cardiovascular Diseases（C-MET Trial）

Who this might be right for
Metabolic Syndrome
Peking University Third Hospital 220
Large-scale testing (Phase 3)UnknownNCT05090410
What this trial is testing

Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid ArthritisJAK InhibitorIL-6 Inhibitor+2 more
Atsushi Kawakami 400
Large-scale testing (Phase 3)Study completedNCT02173457
What this trial is testing

Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Chipscreen Biosciences, Ltd. 740
Large-scale testing (Phase 3)Study completedNCT01703221
What this trial is testing

Omarigliptin (MK-3102) Clinical Trial - Placebo- and Sitagliptin-Controlled Monotherapy Study in Japanese Patients With Type 2 Diabetes Mellitus (MK-3102-020)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 414
Large-scale testing (Phase 3)Study completedNCT00327015
What this trial is testing

BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

Who this might be right for
Diabetes
AstraZeneca 1,306
Testing effectiveness (Phase 2)Study completedNCT01193218
What this trial is testing

Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547
Not applicableWithdrawnNCT04953702
What this trial is testing

Study of the Associations Between Subchondral Insufficiency Fractures of the Knee and Pre-existing Health, Lifestyle, and/or Musculoskeletal Conditions

Who this might be right for
Subchondral Insufficiency Fracture
University of Massachusetts, Worcester
Testing effectiveness (Phase 2)Looking for participantsNCT06846320
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder (GAD)
AbbVie 315
Large-scale testing (Phase 3)Study completedNCT00736879
What this trial is testing

Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 497
Testing effectiveness (Phase 2)Study completedNCT01111955
What this trial is testing

Safety Study of BMS-823778 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Bristol-Myers Squibb 62
Large-scale testing (Phase 3)Study completedNCT00683657
What this trial is testing

Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone

Who this might be right for
Type 2 Diabetes
AstraZeneca 93
Large-scale testing (Phase 3)Study completedNCT00528372
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,067
Load More Results